Singapore, Singapore

Catherine Jane Pallen

This inventor holds 2 USPTO granted patents. Top assignee: Institute of Molecular & Cell Biology. Active years: 1999-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine Jane Pallen. Retrieved from https://idiyas.com/inventor/catherine-jane-pallen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 78(Granted Patents)


Location History:

  • Ridge Crescent, SG (1999)
  • Singapore, SG (2007)

Company Filing History:


Years Active: 1999-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Catherine Jane Pallen

Introduction

Catherine Jane Pallen is a notable inventor based in Singapore, SG. She has made significant contributions to the field of molecular biology, particularly in the area of protein inhibitors. With a total of 2 patents, her work has implications for tumor diagnosis and treatment.

Latest Patents

Catherine's latest patents include a protein tyrosine phosphatase inhibitor, which utilizes a specific compound formula. Additionally, she has developed methods for tumor diagnosis and prognosis, showcasing her innovative approach to addressing critical health issues.

Career Highlights

Catherine is affiliated with the Institute of Molecular and Cell Biology, where she conducts her research and development. Her work at this prestigious institution has allowed her to explore various avenues in molecular biology, contributing to advancements in medical science.

Collaborations

Catherine has collaborated with esteemed colleagues such as Karim Tabiti and Haishan Wang. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Catherine Jane Pallen's contributions to the field of molecular biology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in tumor diagnosis and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…